Table 2:
14-color CLL | Positive Population | Negative Population | Separation Ratio | Range(min-max) | ERIC/ESCCA recommedation |
---|---|---|---|---|---|
| |||||
CD79b BB515 | CD20+ B cells | CD3+ T cells | 21 | 2–63 | ≥15(30) |
CD5 PE | CD3+ T cells | CD19+ B cells | 131 | 85–213 | ≥30(65) |
ROR1 PE/DAZZLE 594 | B-progenitors | T cells | 8 | 6–10 | ≥5 |
CD23 BB700 | CD23+ B cells | T cells | 17 | 7–32 | ≥5 |
CD19 PC7 | CD20+ B cells | CD3+ T cells | 76 | 41–116 | ≥10 |
CD81 APC | CD3+ T cells | Granulocytes | 20 | 12–32 | ≥12(20) |
CD20 APC/FIRE 750 | CD19+ B cells | CD3+ T cells | 29 | 5–63 | ≥10(20) |
CD200 BV421 | CD19+ B cells | CD3+ T cells | 8 | 6–12 | ≥5 |
CD40 BV480 | B cells | T cells | 12 | 8–15 | N/A |
CD43 BV605 | CD3+ T cells | CD20+ B cells | 50 | 14–127 | ≥15(40) |
CD3 BUV395 | T cells | CD19+ B cells | 154 | 37–238 | N/A |
CD10 BUV737 | Granulocytes | T cells | 12 | 5–20 | ≥10 |